fluocinolone acetonide has been researched along with Bacterial Eye Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adán, A; Coelho-Borges, AI; Hernanz, I; Llorenç, V; Moll-Udina, A; Pazos, M; Pelegrín, L; Sainz-de-la-Maza, M | 1 |
Lin, P; Thomas, AS | 1 |
Heinz, C; Pavesio, C | 1 |
1 review(s) available for fluocinolone acetonide and Bacterial Eye Infections
Article | Year |
---|---|
Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: current concepts and emerging therapeutics.
Topics: Anti-Infective Agents; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Panuveitis; Rituximab; Sirolimus; Uveitis, Intermediate; Uveitis, Posterior | 2020 |
2 other study(ies) available for fluocinolone acetonide and Bacterial Eye Infections
Article | Year |
---|---|
Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months.
Topics: Diabetic Retinopathy; Eye Infections, Bacterial; Female; Fluocinolone Acetonide; Glaucoma; Humans; Macular Edema; Male; Prospective Studies; Uveitis | 2023 |
Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
Topics: Cataract; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Recurrence; Treatment Outcome; Uveitis; Visual Acuity | 2022 |